1-10 of 20 results
Allens advises Healthe Care on sale of surgical business to PEP
Healthe Care's surgical hospitals portfolio comprises 12 hospitals and 7 day surgery centres in Australia and New Zealand, which together provide a diverse offering of healthcare services across ...
Allens advises Livingbridge on its acquisition of Everlight Radiology
Everlight provides teleradiology services for providers across the globe from its critical care hubs in the UK, Ireland, Australia and New Zealand. Everlight works with hospitals and clinics to ...
Allens advises Burnet Institute and management shareholders on the sale of 360biolabs
360biolabs is a Melbourne-based contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics. BioAgilytix ...
Allens advises on $1.5bn New Footscray Hospital
The New Footscray Hospital is a critical community asset that will help address the increasing demand from Melbourne’s booming western suburbs. Partner David Donnelly, who led the Allens team, sai ...
Allens advises BGH Capital on acquisition of Healius' Medical Centres business
Allens' Private Equity and Healthcare specialists across a number of practices combined to help BGH deliver a complex carve-out transaction that spanned the COVID period. 'The BGH team has been ...
Allens advises Cigna on new health venture
The joint venture will aim to offer a range of services for the benefit of health fund members in Australia, to deliver better health outcomes and risk management. Each company will contribute $10 ...
Corporate culture an increasing legal and reputational risk
Significantly, the report's findings move beyond broad recommendations, identifying the key factors singled out by the law and regulators as drivers of corporate culture and naming general counsel, ...
Allens acts for Healthscope on Asian pathology sale
Allens has advised Healthscope Limited, one of Australia's leading private healthcare operators, on the sale of its Asian pathology operations in Singapore, Malaysia and Vietnam to funds managed by ...
Allens advises Clearskincare on $127.4m acquisition
Allens has advised the founders of Clearskincare on the sale of the brand's clinic and products businesses to Australian Pharmaceutical Industries (API) for $127.4 million. Under the deal, API will ...
Allens advises PEP on acquisition of LifeHealthcare
Allens has advised private equity fund manager Pacific Equity Partners (PEP) in relation to the acquisition of ASX-listed LifeHealthcare Group Limited (LifeHealthcare) by Pacific Health Supplies ...